Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Teligent Pharma, Inc.

Teligent Pharma, Inc. Recalls

All product recalls associated with Teligent Pharma, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Mar 2022

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 41–60 of 64 recalls

Diclofenac Sodium Solution (Teligent) – Defective Container (2021)

Defective Container

Class IIModerate

FDAOct 19, 2021Nationwide• Teligent Pharma, Inc.

Diclofenac Sodium Solution (Teligent) – Defective Container (2021)

Defective Container

Class IIModerate

FDAOct 19, 2021Nationwide• Teligent Pharma, Inc.

Lidocaine Hydrochloride Topical Solution (Teligent) – Superpotent Drug (2021)

Superpotent Drug

Class IHigh

1 234

Page 3 of 4Next

FDA

Oct 12, 2021

Nationwide

• Teligent Pharma, Inc.

Lidocaine Hydrochloride Topical Solution (Teligent) – Manufacturing Deviation (2021)

CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.

Class IIModerate

FDAOct 12, 2021Nationwide• Teligent Pharma, Inc.

Lidocaine Hydrochloride Topical Solution (Teligent Pharma) – CGMP deviations (2021)

CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.

Class IIModerate

FDAOct 12, 2021Nationwide• Teligent Pharma, Inc.

Betamethasone Dipropionate Lotion (Teligent) – Stability Failure (2021)

Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing

Class IIModerate

FDAAug 23, 2021Nationwide• Teligent Pharma, Inc.